Farther Finance Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Farther Finance Advisors’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-43	Closed	-$1.78K	–	4158
2024 Q2	$1.78K	Buy	43 +40	+1,333%	+$1.67K	﹤0.01%	2840
2024 Q1	$127	Hold	3	–	–	﹤0.01%	3343
2023 Q4	$127	Buy	+3	New	+$86	﹤0.01%	3284

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Farther Finance Advisors's CERE Position: Q3 2024 in Review

Farther Finance Advisors sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 43 shares — an estimated $1.78K sold.

Farther Finance Advisors first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $1.78K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Farther Finance Advisors reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Farther Finance Advisors sold 43 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.78K.
Farther Finance Advisors first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Farther Finance Advisors's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.78K in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Farther Finance Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.